9 research outputs found

    Linking named entities to Wikipedia

    Get PDF
    Natural language is fraught with problems of ambiguity, including name reference. A name in text can refer to multiple entities just as an entity can be known by different names. This thesis examines how a mention in text can be linked to an external knowledge base (KB), in our case, Wikipedia. The named entity linking (NEL) task requires systems to identify the KB entry, or Wikipedia article, that a mention refers to; or, if the KB does not contain the correct entry, return NIL. Entity linking systems can be complex and we present a framework for analysing their different components, which we use to analyse three seminal systems which are evaluated on a common dataset and we show the importance of precise search for linking. The Text Analysis Conference (TAC) is a major venue for NEL research. We report on our submissions to the entity linking shared task in 2010, 2011 and 2012. The information required to disambiguate entities is often found in the text, close to the mention. We explore apposition, a common way for authors to provide information about entities. We model syntactic and semantic restrictions with a joint model that achieves state-of-the-art apposition extraction performance. We generalise from apposition to examine local descriptions specified close to the mention. We add local description to our state-of-the-art linker by using patterns to extract the descriptions and matching against this restricted context. Not only does this make for a more precise match, we are also able to model failure to match. Local descriptions help disambiguate entities, further improving our state-of-the-art linker. The work in this thesis seeks to link textual entity mentions to knowledge bases. Linking is important for any task where external world knowledge is used and resolving ambiguity is fundamental to advancing research into these problems

    A Systematic Review and Meta-Analysis of the Incidence of Injury in Professional Female Soccer

    Get PDF
    The epidemiology of injury in male professional football is well documented and has been used as a basis to monitor injury trends and implement injury prevention strategies. There are no systematic reviews that have investigated injury incidence in women’s professional football. Therefore, the extent of injury burden in women’s professional football remains unknown. PURPOSE: The primary aim of this study was to calculate an overall incidence rate of injury in senior female professional soccer. The secondary aims were to provide an incidence rate for training and match play. METHODS: PubMed, Discover, EBSCO, Embase and ScienceDirect electronic databases were searched from inception to September 2018. Two reviewers independently assessed study quality using the Strengthening the Reporting of Observational Studies in Epidemiology statement using a 22-item STROBE checklist. Seven prospective studies (n=1137 professional players) were combined in a pooled analysis of injury incidence using a mixed effects model. Heterogeneity was evaluated using the Cochrane Q statistic and I2. RESULTS: The epidemiological incidence proportion over one season was 0.62 (95% CI 0.59 - 0.64). Mean total incidence of injury was 3.15 (95% CI 1.54 - 4.75) injuries per 1000 hours. The mean incidence of injury during match play was 10.72 (95% CI 9.11 - 12.33) and during training was 2.21 (95% CI 0.96 - 3.45). Data analysis found a significant level of heterogeneity (total Incidence, X2 = 16.57 P < 0.05; I2 = 63.8%) and during subsequent sub group analyses in those studies reviewed (match incidence, X2 = 76.4 (d.f. = 7), P <0.05; I2 = 90.8%, training incidence, X2 = 16.97 (d.f. = 7), P < 0.05; I2 = 58.8%). Appraisal of the study methodologies revealed inconsistency in the use of injury terminology, data collection procedures and calculation of exposure by researchers. Such inconsistencies likely contribute to the large variance in the incidence and prevalence of injury reported. CONCLUSIONS: The estimated risk of sustaining at least one injury over one football season is 62%. Continued reporting of heterogeneous results in population samples limits meaningful comparison of studies. Standardising the criteria used to attribute injury and activity coupled with more accurate methods of calculating exposure will overcome such limitations

    Grammar and Corpora 2016

    Get PDF
    In recent years, the availability of large annotated corpora, together with a new interest in the empirical foundation and validation of linguistic theory and description, has sparked a surge of novel work using corpus methods to study the grammar of natural languages. This volume presents recent developments and advances, firstly, in corpus-oriented grammar research with a special focus on Germanic, Slavic, and Romance languages and, secondly, in corpus linguistic methodology as well as the application of corpus methods to grammar-related fields. The volume results from the sixth international conference Grammar and Corpora (GaC 2016), which took place at the Institute for the German Language (IDS) in Mannheim, Germany, in November 2016.Die Verfügbarkeit großer annotierter und durchsuchbarer Korpora, verbunden mit einem neuerwachten Interesse an der empirischen Grundlegung und Validierung linguistischer Theorie und Beschreibung hat in letzter Zeit zu einer regelrechten Welle interessanter Arbeiten zur Grammatik natürlicher Sprachen geführt. Dieser Band präsentiert zum einen neuere Entwicklungen in der korpusorientierten Forschung zur Grammatik germanischer, romanischer und slawischer Sprachen und zum anderen innovative Ansätze in der einschlägigen korpuslinguistischen Methodologie, die auch Anwendung im Umfeld der Grammatik finden. Der Band fasst die Beiträge der sechsten internationalen Konferenz Grammar and Corpora zusammen, die im November 2016 am Institut für Deutsche Sprache (IDS) in Mannheim stattfand

    Drug development progress in duchenne muscular dystrophy

    Get PDF
    Duchenne muscular dystrophy (DMD) is a severe, progressive, and incurable X-linked disorder caused by mutations in the dystrophin gene. Patients with DMD have an absence of functional dystrophin protein, which results in chronic damage of muscle fibers during contraction, thus leading to deterioration of muscle quality and loss of muscle mass over time. Although there is currently no cure for DMD, improvements in treatment care and management could delay disease progression and improve quality of life, thereby prolonging life expectancy for these patients. Furthermore, active research efforts are ongoing to develop therapeutic strategies that target dystrophin deficiency, such as gene replacement therapies, exon skipping, and readthrough therapy, as well as strategies that target secondary pathology of DMD, such as novel anti-inflammatory compounds, myostatin inhibitors, and cardioprotective compounds. Furthermore, longitudinal modeling approaches have been used to characterize the progression of MRI and functional endpoints for predictive purposes to inform Go/No Go decisions in drug development. This review showcases approved drugs or drug candidates along their development paths and also provides information on primary endpoints and enrollment size of Ph2/3 and Ph3 trials in the DMD space
    corecore